Hypertension Artur Beltrame RibeiroOsvaldo Kohlmann JrOswaldo Luiz Ramos Section 1 27 October 2012 Pages: 1 - 5
Antihypertensive Drugs Interacting with α- and β-Adrenoceptors P. A. van Zwieten Section 1 27 October 2012 Pages: 6 - 19
Experimental Studies on the Neurocardiovascular Effects of Urapidil Richard A. GillisKenneth J. KellarKenneth Dretchen Section 1 27 October 2012 Pages: 20 - 33
Effects of α-Adrenoceptor Blockers on Renal Function and Blood Pressure Adjustment in Human Hypertension Gastone Leonetti Section 2 27 October 2012 Pages: 53 - 59
Systemic and Regional Haemodynamic Profile of Diuretics and α- and β-Blockers Albert MimranGuilhem Ducailar Section 2 27 October 2012 Pages: 60 - 69
Haemodynamic Effects of Urapidil in Arterial Hypertension and Congestive Heart Failure Franz H. Messerli Section 2 27 October 2012 Pages: 70 - 73
Renal Haemodynamic and Neurohumoral Responses to Urapidil in Hypertensive Man P. W. de LeeuwP. N. van EsW. H. Birkenhäger Section 2 27 October 2012 Pages: 74 - 77
The Development and Progression of Chronic Renal Disease Robert G. Narins Section 3 27 October 2012 Pages: 78 - 82
Effects of Different Antihypertensive Drugs on Left Ventricular Function Raúl Oliveri Section 3 27 October 2012 Pages: 83 - 89
Comparison between the Effects of Urapidil and Methyldopa on Left Ventricular Hypertrophy and Haemodynamics in Humans Carlos A. FeldsteinAntonio O. OlivieriRubén Porto Sabarís Section 3 27 October 2012 Pages: 90 - 97
Mechanisms of Complete Baroreceptor Resetting in Hypertension Eduardo Moacyr Krieger Section 4 27 October 2012 Pages: 98 - 103
Neural Control of Circulation Before and After Intravenous Urapidil in Essential Hypertension G. GrassiG. ParatiG. Mancia Section 4 27 October 2012 Pages: 104 - 110
Systemic Arterial Hypertension and Coronary Atherosclerosis Gustavo Sánchez TorresCarlos Posadas RomeroIsmael Hernández Santamaría Section 4 27 October 2012 Pages: 111 - 117
Serum Lipoproteins During Treatment with Antihypertensive Drugs Peter WeidmannClaudia FerrierBernhard N. Trost Section 4 27 October 2012 Pages: 118 - 134
Hypertension and Diabetes Maria Teresa ZanellaRegina C. M. SantiagoArtur B. Ribeiro Section 4 27 October 2012 Pages: 135 - 141
Responders and Non-Responders to Antihypertensive Treatment C. J. Bulpitt Section 5 27 October 2012 Pages: 142 - 146
Efficacy of Urapidil in the Management of Essential Hypertension J. RosenthalR. HaerlinW. Wurst Section 5 27 October 2012 Pages: 147 - 155
Double-Blind Comparison of Urapidil and Prazosin in the Treatment of Patients with Essential Hypertension Yoshihiro Kanekothe Urapidil Study Group in Japan Section 5 27 October 2012 Pages: 156 - 163
Comparison of Urapidil and Atenolol in Hypertension Esther TörökMaria WagnerMarta Podmaniczky Section 5 27 October 2012 Pages: 164 - 172
Efficacy of Once-Daily Urapidil Treatment in Mild or Moderate Essential Hypertension Assessed by Ambulatory 24-Hour Blood Pressure Monitoring Bruno TrimarcöG. RosielloM. Volpe Section 5 27 October 2012 Pages: 173 - 181
Guidelines for the Treatment of Mild Hypertension W. H. BirkenhägerP. W. de Leeuw Section 6 27 October 2012 Pages: 182 - 187
Urapidil in the Treatment of Hypertension Clive Rosendorff Section 6 27 October 2012 Pages: 188 - 192